Contract Laboratory has received the following incoming Laboratory Test Requests which need to be fulfilled! These Laboratory Test Requests are received from a variety of sources ranging from start-up companies to large, multinational Fortune 500 corporations, international organizations, well-respected universities and government agencies that are actively seeking Independent, Third-Party Cell Lines and Cultures Laboratories to perform their Cell Lines and Cultures Testing, Analysis, Assays, Product Development, Scientific Research Experiments, Inspections, Certifications, and Engineering Projects. If you are a Cell Lines and Cultures laboratory that would like more information on these Cell Lines and Cultures projects, please visit Register Laboratories or call toll free 1-855-377-6821.
Preclinical Contract Research Organization neededed for Influenza vaccination efficacy study in a specific strain of KO mice. Vaccination would be followed by challenge with influenza virus. Plasma should be collected before vaccination and at 4 weeks. This should be followed by challenge with the Influenza virus and two weeks of survival curve .Vaccination would be IM , as in humans and infection intranasal.
Molecular Biology / Bioanalytical Laboratory needed for up to three university-based experiments involving human cell lines:
Experiment #1: Test up to 5 human cell lines (i.e. liver, kidney, etc...). Formalinize these cell lines in order to have a bank ready to be used. Then culture peripheral blood stem cells,apply the different formalin treated cells into the growth media, and determine what occurs. I am looking to determine if differentiation is stimulated toward the cell lines that were added. Is there inhibition or is there no reaction?
Experiment #2: Culture peripheral stem cells, add various growth factors (ex. neupogen), and determine if cell expansion is stimulated
Experiment #3: Growth of autologous stem cells on an autologous feeder layer (cells and feeder layer from the same patient). Looking to find what numbers
FDA GLP Preclinical Laboratory needed for PCR viral testing of two regenerative drug products and raw materials using Pharmacopeia methods: 1. HIV (anti-HIV (I/II), 2. Human T-Lymphotropic virus I and II 3. Cytomegalovirus 4. Epstein-Bar virus 5. Hepatitis C 6. HBV (HBsAg & anti-HBC)
In order to stay in line with the pharmacopeia guidelines, we would like to perform detection of the former viruses on our products with the PCR method.
GLP Compliant Laboratory needed for ongoing testing of regenerative drug development (Cell Therapy Hellas) Test for: 1. HIV (anti-HIV (I/II), negative <1.0) 2. Human T-Lymphotropic virus I and II 3. Cytomegalovirus (antibodies for cytomegalovirus IgG, negative ,6.0 AU/ml; antibodies for cytomegalovirus IgM, negative 0.9 IV) 4. Epstein-Bar virus (antibodies for Epstein-Barr IgG, negative 0.19 AU/ml; antibodies for Epstein-Barr IgM, negative 0.19 AU/ml; antibodies EBV-NA IgG, negative <0.91) 5. Hepatitis C (antibodies for hepatitis C, negative <1.0) 6. HBV (HBsAg & anti-HBC)
Biosafety Level BSL-2 Laboratory needed for conducting research on oncolytic viruses based on HSV1, Herpes Simplex Virus. We are looking for services for titrating how much HSV1 virus is present in our samples (e.g. plaque assays) and/or assays measuring cytopathic affect of virus in samples (CPE). We can provide cell lines for these assays if needed. If possible, we would also like to provide cancer cell lines to use for testing after titration is done in a more common cell line (e.g. vero cells).